Skip to content

Venture Capital – Earning its place in a multi asset portfolio

By Matthew Moynes, Assistant Director of Investor Relations, Calculus Capital Synonymous with UK venture capital investing is the attractive tax incentives provided by  HMRC which help stimulate the flow of investor capital into this important asset class. This effective risk mitigation tool can often mean the integrity of the EIS and VCT investment structure can … Continued

Scancell: As Covid mutates, the vaccine makers are adapting too

Scancell featured in the Guardian Focus on the exciting potential of T-cell immunity is spurring the sector on to create a new generation of jabs The speed at which scientists worked to develop the first Covid jabs was unprecedented. Just nine months after the UK went into lockdown, 90-year-old Margaret Keenan officially became the first person in … Continued

Genedrive’s rapid point of care COV19 testing kit receives CE-IVD certification

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that further to the announcement of 29 November 2021, its rapid point of care Genedrive® COV19-ID Kit has received CE-IVD certification under the European Communities Council Directive 98/79.   The Genedrive® COV19-ID kit is a rapid molecular diagnostic test that delivers positive results as quickly as 7.5 minutes and negative results at 17 minutes.  In … Continued

Calculus invests in Hinterview

UK-based technology company Hinterview has today announced that it has raised £3m in Series A funding. The award-winning video platform for the recruitment sector has experienced soaring demand for their technology, with growth continuing this year as the recruitment industry bounces back in a new era of hybrid-first working. This Series A round, led by … Continued

Scancell: Phase 2 clinical trial of lead immunotherapy product commences

First patient dosed in SCIB1 Phase 2 clinical trial Trial to assess whether the addition of SCIB1 to pembrolizumab (Keytruda®) will result in an improvement in the tumour response rate and overall survival in patients with advanced melanoma Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious … Continued

Spectral MD announce early results from clinical study

Accuracies of 92% and 88% in detection of severe thermal burn injury in adults and children, respectively Article published in Journal of Burn Care and Research on histological burn depth research LONDON, U.K. AND DALLAS, TX, U.S. Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company that develops proprietary AI algorithms and optical technology for … Continued

Blu Wireless showcase new 360° Tactical Vehicle Node

Blu Wireless have been showcasing their new 360° Tactical Vehicle Node, which enables scalable tactical connectivity between vehicles. In contrast to commercial networks, tactical 5G military networks necessitate systems which are standalone, secure, can be easily interfaced to existing tactical equipment and are resistant to single point of failure. Blu Wireless is a firm that … Continued